Underlying EBITDA fell to €379m in H1 2026 amid margin pressure from lower prices and higher input costs, with special charges of €320m for impairments and restructuring. Volume growth in key segments and improved trading momentum support a positive outlook, despite ongoing cost challenges.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.